65. 原発性免疫不全症候群 Primary immunodeficiency Clinical trials / Disease details


臨床試験数 : 500 薬物数 : 614 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 217

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05256017
(ClinicalTrials.gov)
December 30, 202117/1/2022Safety and Tolerability Study of Acoziborole in g-HAT Seropositive SubjectsSafety and Tolerability Study of Acoziborole in g-HAT Seropositive Non-parasitologically Confirmed Subjects: a Multicentre Randomised Double-blind Placebo-controlled StudyTrypanosomiasis, African;Trypanosoma Brucei Gambiense; Infection;Sleeping SicknessDrug: Acoziborole;Drug: PlaceboDrugs for Neglected DiseasesNULLRecruiting15 YearsN/AAll1200Phase 2/Phase 3Congo, The Democratic Republic of the;Guinea
2NCT03087955
(ClinicalTrials.gov)
October 11, 20167/3/2017Prospective Study on Efficacy and Safety of Acoziborole (SCYX-7158) in Patients Infected by Human African Trypanosomiasis Due to T.b. GambienseEfficacy and Safety Study of Acoziborole (SCYX-7158) in Patients With Human African Trypanosomiasis (HAT) Due to Trypanosoma Brucei Gambiense: a Multicentre, Open-label, Prospective StudyTrypanosomiasis, African;Gambiense Trypanosomiasis;Sleeping SicknessDrug: Acoziborole (SCYX-7158)Drugs for Neglected DiseasesNULLCompleted15 YearsN/AAll260Phase 2/Phase 3Congo, The Democratic Republic of the;Guinea